Acquisition Interest Potential integration and collaboration opportunities with Gore & Associates given the announced definitive agreement to acquire Conformal Medical, signaling strategic interest in the LAAO space and potential channel expansion.

Product Evolution Opportunity to engage on CLAAS AcuFORM System development and related LAAO solutions, aligning with hospitals seeking cutting-edge devices with broader anatomic coverage and fewer sizing options.

Clinical Footprint Leverage ongoing GLACE study results and pivotal trial milestones to position Conformal offerings to academic centers and high-volume cardiac care networks focused on stroke prevention in non-valvular atrial fibrillation.

Funding Signals With substantial funding previously raised and a solid revenue range, there is interest from investors and large medtech players for partnerships, licensing, or co-development agreements to scale manufacturing and distribution.

Manufacturing Readiness Highlight the company’s nimble product development for LAAO devices and readiness to scale with contract manufacturers, targeting mid-to-large medical device distributors and accredited distributors seeking innovative stroke prevention technologies.